3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
6
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Colorectal Neoplasms
1
Interventions
Oncolytic Virotherapy
2
tucatinib
1
trifluridine tipiracil drug combination
1
tribenoside (combination)
1
tribenoside
1
trastuzumab deruxtecan
1
tipiracil
1
sotorasib
1
sintilimab
1
regorafenib
1
polyethylene glycol 400
1
penpulimab
1
palbociclib
1
montelukast
1
encorafenib
1
binimetinib
1
balstilimab
1
adagrasib
1
Trifluridine
1
Tobacco Use Cessation Devices
1
Tablets
1
Suppositories
1
Standard of Care
1
Specimen Handling
1
Receptor Protein-Tyrosine Kinases
1
Radiosurgery
1
Polyethylene Glycols
1
Pentoxifylline
1
Panitumumab
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Colorectal Neoplasms
×
Control Groups
×
Clear all
NCT02304978
2025-12-26
TF
University Hospital, Lille
Phase EARLY_PHASE1
Completed
26 enrolled